Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

July 16, 2014

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Vascular Cognitive ImpairmentQi Zhi Tong Luo CapsuleRandomized Controlled Trial
Interventions
DRUG

Qi Zhi Tong Luo capsule

Patients were receiveed Qi Zhi Tong Luo Capsule 4 capsules, 2 times per day for 24 weeks. QZTL capsule, a traditional Chinese medicine. Each capsule was weighted 0.5g.

DRUG

Placebos

Patients were allocated to placebo, 4 capsules, 2 times per day for 24 weeks.To preserve blinding, the placebo had an identical taste and appearance to the experimental drugs. Placebo (batch number: 20140805) were produced by Shanxi Zhendong Pharmaceutical Co., Ltd.

Trial Locations (1)

100700

Dongzhimen Hospital ,Beijing University of Chinese Medicine, Beijing

All Listed Sponsors
collaborator

Shanxi Zhendong Pharmacy Co., Ltd

INDUSTRY

lead

Dongzhimen Hospital, Beijing

OTHER

NCT04301466 - Efficacy and Safety of Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment | Biotech Hunter | Biotech Hunter